40.16

1.49% -0.5564

Scholar Rock Holding Corp (SRRK)

Overview News Price History Option Chain Financials Discussions Forecast

Scholar Rock Holding Corp stock is traded at $40.16, with a volume of 172.44K. It is down -1.49% in the last 24 hours and down -0.91% over the past month. Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Previous Close:

$40.72

Open:

$40.7

24h Volume:

172.44K

Relative Volume:

0.17

Market Cap:

$3.81B

Revenue:

$47.30M

Net Income/Loss:

$-225.97M

P/E Ratio:

-17.09

EPS:

-2.35

Net Cash Flow:

$-188.86M

1W Performance:

-0.66%

1M Performance:

-0.91%

6M Performance:

+386.22%

1Y Performance:

+150.39%

1-Day Range:

$39.95

$41.28

1-Week Range:

$39.31

$42.23

52-Week Range:

$6.76

$46.98

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name

Scholar Rock Holding Corp

Sector

Healthcare (1187)

Industry

Biotechnology (679)

Phone

857-259-3860

Address

301 BINNEY STREET, CAMBRIDGE, MA

Employee

150

Twitter

@ScholarRock

Next Earnings Date

2024-11-12

Latest SEC Filings

SRRK's Discussions on Twitter

Compare SRRK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRRK Scholar Rock Holding Corp	40.15	3.81B	47.30M	-225.97M	-188.86M	-2.35
VRTX Vertex Pharmaceuticals Inc	473.81	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	716.80	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	653.26	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	274.52	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.28	28.75B	3.30B	-501.07M	1.03B	-2.1146

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-26-24	Reiterated	H.C. Wainwright	Buy
Oct-07-24	Reiterated	H.C. Wainwright	Buy
Mar-28-24	Initiated	Raymond James	Strong Buy
Oct-25-23	Upgrade	Jefferies	Hold → Buy
Apr-03-23	Resumed	Piper Sandler	Overweight
Sep-19-22	Resumed	H.C. Wainwright	Buy
Jul-12-22	Initiated	Truist	Buy
Mar-23-22	Initiated	H.C. Wainwright	Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Nov-19-21	Initiated	Piper Sandler	Overweight
Apr-26-21	Resumed	Credit Suisse	Outperform
Jan-11-21	Initiated	Credit Suisse	Outperform
Jan-06-21	Initiated	JP Morgan	Overweight
Mar-12-20	Initiated	Robert W. Baird	Outperform

View All

Scholar Rock Holding Corp Stock (SRRK) Latest News

04:26 AM

KBC Group NV Buys Shares of 3,020 Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World

04:26 AM

02:41 AM

E. Ohman J or Asset Management AB Sells 68,500 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat

02:41 AM

Feb 05, 2025